Tyme Technologies Stock Forecast, Price & News

Tyme Technologies (NASDAQ:TYME) Frequently Asked Questions

What stocks does MarketBeat like better than Tyme Technologies?

Wall Street analysts have given Tyme Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tyme Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Tyme Technologies?

Tyme Technologies saw a decline in short interest in August. As of August 13th, there was short interest totaling 3,340,000 shares, a decline of 31.7% from the July 29th total of 4,890,000 shares. Based on an average daily volume of 7,470,000 shares, the days-to-cover ratio is presently 0.4 days. Approximately 2.9% of the shares of the stock are sold short.
View Tyme Technologies' Short Interest.

When is Tyme Technologies' next earnings date?

Tyme Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Tyme Technologies.

How were Tyme Technologies' earnings last quarter?

Tyme Technologies, Inc. (NASDAQ:TYME) announced its quarterly earnings results on Tuesday, August, 10th. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01.
View Tyme Technologies' earnings history.

How has Tyme Technologies' stock price been impacted by COVID-19 (Coronavirus)?

Tyme Technologies' stock was trading at $1.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TYME shares have increased by 2.9% and is now trading at $1.08.
View which stocks have been most impacted by COVID-19.

Who are Tyme Technologies' key executives?

Tyme Technologies' management team includes the following people:

• Steve Hoffman, Chairman & Chief Science Officer (LinkedIn Profile)
• Richard Anthony Cunningham, Chief Executive Officer & Director
• Frank L. Porfido, Chief Financial Officer
• Jan M. van Tornout, Chief Medical Officer
• Jonathan M. Eckard, Chief Business Officer

Who are some of Tyme Technologies' key competitors?

Some companies that are related to Tyme Technologies include Shattuck Labs (STTK), Oramed Pharmaceuticals (ORMP), Collegium Pharmaceutical (COLL), OrganiGram (OGI), Veru (VERU), Lexicon Pharmaceuticals (LXRX), Immuneering (IMRX), Eagle Pharmaceuticals (EGRX), Mersana Therapeutics (MRSN), Emisphere Technologies (EMIS), PyroGenesis Canada (PYR), Imago BioSciences (IMGO), Rhythm Pharmaceuticals (RYTM), Silence Therapeutics (SLN) and Pharming Group (PHAR).
View all of TYME's competitors.

What other stocks do shareholders of Tyme Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tyme Technologies investors own include Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Allena Pharmaceuticals (ALNA), OpGen (OPGN), Selecta Biosciences (SELB), MEI Pharma (MEIP), Pfizer (PFE) and SCYNEXIS (SCYX).

What is Tyme Technologies' stock symbol?

Tyme Technologies trades on the NASDAQ under the ticker symbol "TYME."

Who are Tyme Technologies' major shareholders?

Tyme Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.81%), Millennium Management LLC (1.23%), BlackRock Inc. (1.11%), Geode Capital Management LLC (0.48%), State Street Corp (0.23%) and Ergoteles LLC (0.18%). Company insiders that own Tyme Technologies stock include David Carberry, Diana F Cantor, Douglas A Michels, James Biehl, Michael Demurjian, Steve Hoffman and Tornout Jan M Van.
View institutional ownership trends for Tyme Technologies.

Which major investors are selling Tyme Technologies stock?

TYME stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Northern Trust Corp, Geode Capital Management LLC, Vanguard Group Inc., Charles Schwab Investment Management Inc., Susquehanna International Group LLP, and Bank of New York Mellon Corp. Company insiders that have sold Tyme Technologies company stock in the last year include Diana F Cantor, Michael Demurjian, and Steve Hoffman.
View insider buying and selling activity for Tyme Technologies or view top insider-selling stocks.

Which major investors are buying Tyme Technologies stock?

TYME stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Ergoteles LLC, Qube Research & Technologies Ltd, Pathstone Family Office LLC, Pathstone Family Office LLC, Simplex Trading LLC, Boothbay Fund Management LLC, and LMR Partners LLP. Company insiders that have bought Tyme Technologies stock in the last two years include David Carberry, Douglas A Michels, James Biehl, Michael Demurjian, Steve Hoffman, and Tornout Jan M Van.
View insider buying and selling activity for Tyme Technologies or or view top insider-buying stocks.

How do I buy shares of Tyme Technologies?

Shares of TYME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tyme Technologies' stock price today?

One share of TYME stock can currently be purchased for approximately $1.08.

How much money does Tyme Technologies make?

Tyme Technologies has a market capitalization of $185.98 million.

How many employees does Tyme Technologies have?

Tyme Technologies employs 18 workers across the globe.

What is Tyme Technologies' official website?

The official website for Tyme Technologies is www.tymeinc.com.

Where are Tyme Technologies' headquarters?

Tyme Technologies is headquartered at 17 STATE STREET 7TH FLOOR, NEW YORK NY, 10004.

How can I contact Tyme Technologies?

Tyme Technologies' mailing address is 17 STATE STREET 7TH FLOOR, NEW YORK NY, 10004. The company can be reached via phone at (212) 461-2315 or via email at [email protected].